Rare diseases
Investigational molecules
Locations
Back to Poland955 clinical trials in Poznan, Poland across 11 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
PolandA Phase 3 Randomized Study of mRNA‑4157 plus Pembrolizumab as Adjuvant Therapy in Patients with Completely Resected Stage I Non‑Small Cell Lung Cancer
PolandPhase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
PolandEvaluation of Anifrolumab Subcutaneous Treatment in Immunosuppressant‑Naïve and Biologic‑Naïve Patients with Systemic Lupus Erythematosus
PolandBI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases
PolandOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
PolandLong-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
PolandBI 3000202 in Patients with Moderate to Severe Systemic Lupus Erythematosus
PolandA study to evaluate the safety and effectiveness of dextromethorphan, deramciclane fumarate, and deramciclane in treating agitation in people with Alzheimer's disease
PolandA study to evaluate the safety and how the body uses ublituximab injections in patients with multiple sclerosis
PolandA study to evaluate the effectiveness of barzolvolimab in participants with cold urticaria and symptomatic dermographism
PolandA study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.
PolandThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on meningococcal vaccines and respiratory syncytial virus prevention. Studies include testing new conjugate vaccines in infants and evaluating immune responses in older adults.
Multiple age groups are being studied to ensure comprehensive protection against infectious diseases.
Innovative research into psoriatic conditions and inflammatory skin disorders. Studies evaluating new treatments for plaque psoriasis and psoriatic arthritis.
Focus on developing targeted therapies for chronic inflammatory skin conditions.
Advanced research in bladder cancer and other oncological conditions. Studies combining immunotherapy with traditional treatments for enhanced efficacy.
Investigating novel combination therapies and targeted treatments for various cancer types.
Comprehensive studies addressing chronic kidney disease, obesity, and cardiovascular conditions. Research focuses on innovative treatment approaches and disease management.
Evaluating new therapeutic options for long-term disease management and prevention.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
